This federal contract opportunity has been awarded to on September 17, 2025.
DEPT OF DEFENSE awarded this contract to for $485,895 on September 17, 2025, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
On 17 September 2025, Joint Base Lewis McChord Health Contracting Branch awarded sole source Indefinite Delivery Indefinite Quantity to Qiagen, LLC, 19300 Germantown Road Germantown, MD 20874-1415 for supplies: QuantiFERON TB Gold-Plus assay reagents for running QuantiFERON TB-Gold Plus for the detection of Mycobacterium Tuberculosis immune responses by enzyme immunoassay (EIA), for Madigan Army Medical Center, Tacoma WA 98431. This award was in accordance with FAR 13.106-l(b)(l). IAW FAR 5.301 this serves as the award notice under Solicitation W81K0225QA107 resulting in Contract Award W81K0225DA026. The North American Industry Classification Systems (NAICS) code for this work is 325413, with business size standard of 1,250 employees. The NAICS is for In-Vitro Diagnostic Substance Manufact
The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in FORT SHAFTER, HI. This set-aside designation means eligible businesses face reduced competition from larger firms.
Looking for more opportunities?
Browse our full directory of government contracts